(RTTNews) - Radius Health Inc. (RDUS) announced positive results from the ATOM Phase 3 Study evaluating TYMLOS or abaloparatide 80mcg subcutaneous (SC) for use in males with osteoporosis. The company ...

Scientists have developed a new platform for single-atom catalysis. The system isolates metal atoms on carefully designed polymer chains. It aims to boost efficiency and selectivity in chemical ...